共 355 条
[1]
McNeil MM(2001)Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997 Clin Infect Dis 33 641-647
[2]
Nash SL(2010)Emerging invasive fungal infections An Pediatr (Barc) 73 52.e1-52.e6
[3]
Hajjeh RA(2008)Advances in antifungal therapy Annu Rev Med 59 361-379
[4]
Phelan MA(2008)In search of the holy grail of antifungal therapy Trans Am Clin Climatol Assoc 119 197-215
[5]
Conn LA(2009)Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections Drugs 69 361-92
[6]
Plikaytis BD(2009)Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents Clin Infect Dis 48 1441-58
[7]
Warnock DW(2009)New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance Expert review of anti-infective therapy 7 981-998
[8]
Alvez F(1998)Lipid formulations of amphotericin B: clinical efficacy and toxicities Clin Infect Dis 27 603-18
[9]
Figueras C(2008)Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products Antimicrob Agents Chemother 52 259-268
[10]
Roselló E(2009)Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis J Antimicrob Chemother 63 526-533